Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B.
Höner Zu Siederdissen C, Rinker F, Maasoumy B, Wiegand SB, Filmann N, Falk CS, Deterding K, Port K, Mix C, Manns MP, Herrmann E, Wedemeyer H, Kraft AR, Cornberg M. Höner Zu Siederdissen C, et al. Among authors: wiegand sb. J Infect Dis. 2016 Nov 15;214(10):1492-1497. doi: 10.1093/infdis/jiw412. Epub 2016 Sep 7. J Infect Dis. 2016. PMID: 27609808
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D.
Maasoumy B, Wiegand SB, Jaroszewicz J, Bremer B, Lehmann P, Deterding K, Taranta A, Manns MP, Wedemeyer H, Glebe D, Cornberg M. Maasoumy B, et al. Among authors: wiegand sb. Clin Microbiol Infect. 2015 Jun;21(6):606.e1-10. doi: 10.1016/j.cmi.2015.02.010. Epub 2015 Feb 17. Clin Microbiol Infect. 2015. PMID: 25700889 Free article.
Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients.
Wiegand SB, Jaroszewicz J, Potthoff A, Höner Zu Siederdissen C, Maasoumy B, Deterding K, Manns MP, Wedemeyer H, Cornberg M. Wiegand SB, et al. Clin Microbiol Infect. 2015 Jul;21(7):710.e1-9. doi: 10.1016/j.cmi.2015.03.003. Epub 2015 Apr 13. Clin Microbiol Infect. 2015. PMID: 25882360 Free article.
Treatment of naïve patients with chronic hepatitis C genotypes 2 and 3 with pegylated interferon alpha and ribavirin in a real world setting: relevance for the new era of DAA.
Heidrich B, Wiegand SB, Buggisch P, Hinrichsen H, Link R, Möller B, Böker KH, Teuber G, Klinker H, Zehnter E, Naumann U, Busch HW, Maasoumy B, Baum U, Hardtke S, Manns MP, Wedemeyer H, Petersen J, Cornberg M; HepNet Study Group. Heidrich B, et al. Among authors: wiegand sb. PLoS One. 2014 Oct 10;9(10):e108751. doi: 10.1371/journal.pone.0108751. eCollection 2014. PLoS One. 2014. PMID: 25302676 Free PMC article.
ImPortance of IP-10 in hepatitis B.
Cornberg M, Wiegand SB. Cornberg M, et al. Among authors: wiegand sb. Antivir Ther. 2016;21(2):93-6. doi: 10.3851/IMP3014. Epub 2015 Nov 24. Antivir Ther. 2016. PMID: 26598599 No abstract available.
Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
Wiegand SB, Heidrich B, Susser S, Rogalska-Taranta M, Petersen J, Böker KH, Grigorian N, Link R, Naumann U, John C, Lueth S, Malfertheiner P, Manns MP, Wedemeyer H, Sarrazin C, Cornberg M. Wiegand SB, et al. PLoS One. 2015 Dec 23;10(12):e0145622. doi: 10.1371/journal.pone.0145622. eCollection 2015. PLoS One. 2015. PMID: 26699619 Free PMC article.
Increased HEV seroprevalence in patients with autoimmune hepatitis.
Pischke S, Gisa A, Suneetha PV, Wiegand SB, Taubert R, Schlue J, Wursthorn K, Bantel H, Raupach R, Bremer B, Zacher BJ, Schmidt RE, Manns MP, Rifai K, Witte T, Wedemeyer H. Pischke S, et al. Among authors: wiegand sb. PLoS One. 2014 Jan 21;9(1):e85330. doi: 10.1371/journal.pone.0085330. eCollection 2014. PLoS One. 2014. PMID: 24465537 Free PMC article.
27 results